ANI Pharmaceuticals, Inc. - stock earnings
ANIP Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | 1.2 million USD | 131.7 million USD |
| 2023Q3 | 9.9 million USD | 131.8 million USD |
| 2023Q2 | 6.2 million USD | 116.5 million USD |
| 2023Q1 | 1.4 million USD | 106.8 million USD |
| 2022Q4 | -4.2 million USD | 94.2 million USD |
| 2022Q3 | -8.6 million USD | 83.8 million USD |
| 2022Q2 | -14.9 million USD | 73.9 million USD |
| 2022Q1 | -20.1 million USD | 64.5 million USD |
| 2021Q4 | -24.1 million USD | 60.9 million USD |
| 2021Q3 | -4.4 million USD | 52.1 million USD |
| 2021Q2 | -14.1 million USD | 48.6 million USD |
| 2021Q1 | 86000 USD | 54.5 million USD |
| 2020Q4 | -3.6 million USD | 57.3 million USD |
| 2020Q3 | 434000 USD | 53.0 million USD |
| 2020Q2 | -12.3 million USD | 48.5 million USD |
| 2020Q1 | -7.0 million USD | 49.8 million USD |
| 2019Q4 | -4.8 million USD | 48.0 million USD |
| 2019Q3 | 3.9 million USD | 51.3 million USD |
| 2019Q2 | 6.6 million USD | 54.4 million USD |
| 2019Q1 | 449000 USD | 52.9 million USD |
| 2018Q4 | 5.4 million USD | 57.1 million USD |
| 2018Q3 | 5.0 million USD | 50.7 million USD |
| 2018Q2 | 2.8 million USD | 47.3 million USD |
| 2018Q1 | 2.3 million USD | 46.5 million USD |
| 2017Q4 | -9.6 million USD | 47.3 million USD |
| 2017Q3 | 4.7 million USD | 48.2 million USD |
| 2017Q2 | 2.7 million USD | 44.8 million USD |
| 2017Q1 | 1.2 million USD | 36.6 million USD |
| 2016Q4 | -1.1 million USD | 38.2 million USD |
| 2016Q3 | 2.5 million USD | 38.5 million USD |
| 2016Q2 | 1.1 million USD | 31.3 million USD |
| 2016Q1 | 1.3 million USD | 20.6 million USD |
| 2015Q4 | 2.9 million USD | 18.0 million USD |
| 2015Q3 | 4.6 million USD | 20.0 million USD |
| 2015Q2 | 3.6 million USD | 19.5 million USD |
| 2015Q1 | 4.4 million USD | 18.8 million USD |
| 2014Q4 | 21.0 million USD | 21.0 million USD |
| 2014Q3 | 6.7 million USD | 17.4 million USD |
| 2014Q2 | -2.4 million USD | 6.6 million USD |
| 2014Q1 | 3.4 million USD | 10.9 million USD |
| 2013Q4 | 3.4 million USD | 10.5 million USD |
| 2013Q3 | 1.2 million USD | 7.8 million USD |
| 2013Q2 | -4.6 million USD | 6.2 million USD |
| 2013Q1 | -2.3 million USD | 145040 USD |
| 2012Q4 | -4.0 million USD | 2.0 million USD |
| 2012Q3 | -6.1 million USD | 110383 USD |
| 2012Q2 | -7.3 million USD | 108780 USD |
| 2012Q1 | -10.3 million USD | 114000 USD |
| 2011Q4 | -6.6 million USD | 114373 USD |
| 2011Q3 | -12.7 million USD | 182784 USD |
| 2011Q2 | -15.0 million USD | 81003 USD |
| 2011Q1 | -17.3 million USD | 57000 USD |
| 2010Q4 | -13.3 million USD | 143032 USD |
| 2010Q3 | -11.6 million USD | 51331 USD |
| 2010Q2 | -10.8 million USD | ? USD |
| 2010Q1 | -10.5 million USD | 2.3 million USD |
| 2009Q4 | -32.5 million USD | 1.1 million USD |
| 2009Q3 | -6.4 million USD | 10492 USD |
| 2009Q2 | -4.6 million USD | 115163 USD |
| 2009Q1 | -4.1 million USD | 68428 USD |
| 2008Q4 | -1.2 million USD | 3.6 million USD |
| 2008Q3 | -6.6 million USD | 82212 USD |
| 2008Q2 | -6.0 million USD | 25869 USD |
| 2008Q1 | -3.6 million USD | 45597 USD |
| 2007Q4 | -1.7 million USD | 329207 USD |
| 2007Q3 | -1.7 million USD | 43793 USD |
| 2007Q2 | -2.4 million USD | 69446 USD |
| 2007Q1 | -1.8 million USD | 50608 USD |
| 2006Q4 | 9.0 million USD | 14.0 million USD |
| 2006Q3 | -745061 USD | 140324 USD |
| 2006Q2 | -2.2 million USD | 175251 USD |
| 2006Q1 | -3.2 million USD | 84679 USD |
| 2005Q4 | -2.4 million USD | 96971 USD |
| 2005Q3 | -1.9 million USD | 87106 USD |
| 2005Q2 | -2.6 million USD | 45596 USD |
| 2005Q1 | -2.8 million USD | 28677 USD |
| 2004Q4 | -4.1 million USD | 54832 USD |
| 2004Q3 | -2.9 million USD | 10762 USD |
| 2004Q2 | -2.6 million USD | 4976 USD |
| 2004Q1 | -2.4 million USD | 7316 USD |
| 2003Q4 | -1.7 million USD | -55708 USD |
| 2003Q3 | -1.4 million USD | 25399 USD |
| 2003Q2 | -1.6 million USD | ? USD |
| 2003Q1 | -1.2 million USD | 84313 USD |
| 2002Q4 | -411399 USD | 1.8 million USD |
| 2002Q3 | -801001 USD | 962556 USD |
| 2002Q2 | -1.5 million USD | ? USD |
| 2002Q1 | -1.4 million USD | -1.8 million USD |
| 2001Q4 | -1.4 million USD | ? USD |
| 2001Q3 | 349164 USD | 1.7 million USD |
| 2001Q2 | -858913 USD | 50843 USD |
| 2001Q1 | -689900 USD | 1 USD |
| 2000Q4 | -926462 USD | 1 USD |
| 2000Q3 | -620739 USD | 1 USD |
| 2000Q2 | -1.4 million USD | 1 USD |
| 2000Q1 | -455820 USD | 1 USD |
| 1999Q2 | -279386 USD | ? USD |
ANIP Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | 18.8 million USD | 486.8 million USD |
| 2022 | -47.9 million USD | 316.4 million USD |
| 2021 | -42.6 million USD | 216.1 million USD |
| 2020 | -22.5 million USD | 208.5 million USD |
| 2019 | 6.1 million USD | 206.5 million USD |
| 2018 | 15.5 million USD | 201.6 million USD |
| 2017 | -1.1 million USD | 176.8 million USD |
| 2016 | 3.9 million USD | 128.6 million USD |
| 2015 | 15.4 million USD | 76.3 million USD |
| 2014 | 28.7 million USD | 56.0 million USD |
| 2013 | 301000 USD | 30.1 million USD |
| 2012 | -27.7 million USD | 2.3 million USD |
| 2011 | -51.6 million USD | 435160 USD |
| 2010 | -46.2 million USD | 2.5 million USD |
| 2009 | -47.5 million USD | 1.3 million USD |
| 2008 | -17.4 million USD | 3.8 million USD |
| 2007 | -7.6 million USD | 493054 USD |
| 2006 | 2.8 million USD | 14.4 million USD |
| 2005 | -9.7 million USD | 258351 USD |
| 2004 | -12.0 million USD | 77886 USD |
| 2003 | -6.0 million USD | 65494 USD |
| 2002 | -3.8 million USD | 2.8 million USD |
| 2001 | -2.6 million USD | 1.7 million USD |
| 2000 | -3.4 million USD | 2 USD |
| 1999 | -1.4 million USD | 1 USD |
| 1998 | -2.7 million USD | 123061 USD |
ANIP
Price: $67.25
52 week price:
Earnings Per Share: 0.85 USD
P/E Ratio: 108.78
Exchange: NGM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Volume: 67658
Ebitda: 16.4 millionMarket Capitalization: 1.4 billion